{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T07:40:12Z","timestamp":1731656412355,"version":"3.28.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.anndiagpath.2024.152354","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T22:09:39Z","timestamp":1718230179000},"page":"152354","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinicopathological characteristics of methotrexate-related lymphoproliferative disorder of the thyroid: A study of 11 patients"],"prefix":"10.1016","volume":"73","author":[{"given":"Ayana","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuyoshi","family":"Hirokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moe","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Akamizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2024.152354_bb0005","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0010","doi-asserted-by":"crossref","first-page":"IX81","DOI":"10.1093\/annonc\/mdx697.029","article-title":"Methotrexate-associated lymphoproliferative disorder","volume":"28","author":"Yamada","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0015","article-title":"Methotrexate-associated lymphoproliferative disorder in a patient with psoriasis: a case report and review of the literature","volume":"2022","author":"Afonso","year":"2022","journal-title":"Case Rep Hematol"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0020","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.3109\/10428194.2015.1022769","article-title":"Methotrexate-associated lymphoproliferative disorders: management by watchful waiting and observation of early lymphocyte recovery after methotrexate withdrawal","volume":"56","author":"Inui","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0025","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1159\/000507826","article-title":"Importance of imaging procedures in the evaluation of methotrexate-associated lymphoproliferative disorder of the thyroid gland: a case study","volume":"10","author":"Tokumaru","year":"2021","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0030","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1365-2265.2006.02529.x","article-title":"Remission of a primary thyroid lymphoma after methotrexate withdrawal","volume":"64","author":"de Mast","year":"2006","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0035","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4652767","article-title":"Tumor volume kinetic analyses might explain excellent prognoses in young patients with papillary thyroid carcinoma","volume":"2020","author":"Kasahara","year":"2020","journal-title":"J Thyroid Res"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0045","series-title":"The Bethesda system for reporting thyroid cytopathology. Definitions, Criteria, and Explanatory Notes","first-page":"1","article-title":"Overview of diagnostic terminology and reporting","author":"Baloch","year":"2023"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0050","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1507\/endocrj.EJ21-0451","article-title":"B-cell to T-cell ratio as a novel indicator in flow cytometry in the diagnosis of thyroid lymphoma","volume":"69","author":"Suzuki","year":"2022","journal-title":"Endocr J"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3960\/jslrt.20041","article-title":"Clinicopathological evaluation of methotrexate-associated lymphoproliferative disorders with special focus on Epstein-Barr virus-positive mucocutaneous lesions","volume":"60","author":"Shiraiwa","year":"2020","journal-title":"J Clin Exp Hematop"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0060","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3960\/jslrt.19028","article-title":"Immune response in LPD during methotrexate administration (MTX-LPD) in rheumatoid arthritis patients","volume":"59","author":"Saito","year":"2019","journal-title":"J Clin Exp Hematop"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0065","first-page":"1741","article-title":"Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate","volume":"18","author":"Ellman","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0070","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/bjh.17824","article-title":"Retrospective analyses of other iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with rheumatic diseases","volume":"195","author":"Kaji","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0075","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3960\/jslrt.19007","article-title":"Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders","volume":"59","author":"Tokuhira","year":"2019","journal-title":"J Clin Exp Hematop"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0080","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2176\/nmccrj.cr.2019-0241","article-title":"Primary central nervous system methotrexate-associated lymphoproliferative disorder in a patient with rheumatoid arthritis: case report and review of literature","volume":"7","author":"Uneda","year":"2020","journal-title":"NMC Case Rep J"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0085","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/art.40017","article-title":"Rheumatoid arthritis and risk of malignant lymphoma: is the risk still increased?","volume":"69","author":"Hellgren","year":"2017","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0090","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/cas.13249","article-title":"Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types","volume":"108","author":"Gion","year":"2017","journal-title":"Cancer Sci"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0095","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/00000478-199610000-00015","article-title":"Hodgkin\u2019s disease and lymphoproliferations resembling Hodgkin\u2019s disease in patients receiving long-term low-dose methotrexate therapy","volume":"20","author":"Kamel","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0100","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/PAS.0000000000001271","article-title":"Methotrexate-associated lymphoproliferative disorders in patients with rheumatoid arthritis: clinicopathologic features and prognostic factors","volume":"43","author":"Kurita","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0105","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.2169\/internalmedicine.0737-18","article-title":"Methotrexate-associated lymphoproliferative disorder of the stomach presumed to be mucosa-associated lymphoid tissue lymphoma","volume":"57","author":"Ishigaki","year":"2018","journal-title":"Intern Med"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0110","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s10384-016-0439-z","article-title":"Methotrexate-associated orbital lymphoproliferative disorder in a patient with rheumatoid arthritis: a case report","volume":"60","author":"Kobayashi","year":"2016","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0115","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3960\/jslrt.54.187","article-title":"Clinical features and outcomes of 9 patients with immunodeficiency-associated lymphoproliferative disorders treated at a single institution","volume":"54","author":"Kawano","year":"2014","journal-title":"J Clin Exp Hematop"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0120","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/864907","article-title":"Autoimmune thyroid disease in rheumatoid arthritis: a global perspective","volume":"2012","author":"C\u00e1rdenas Rold\u00e1n","year":"2012","journal-title":"Arthritis"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0125","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/jcp.2007.051243","article-title":"Clonal relationship between Hashimoto thyroiditis and thyroid lymphoma","volume":"61","author":"Moshynska","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0130","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1507\/endocrj.EJ18-0348","article-title":"Flow cytometric, gene rearrangement, and karyotypic analyses of 110 cases of primary thyroid lymphoma: a single-institutional experience in Japan","volume":"66","author":"Suzuki","year":"2019","journal-title":"Endocr J"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0135","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s11033-021-06152-z","article-title":"A review on EBV encoded and EBV-induced host microRNAs expression profile in different lymphoma types","volume":"48","author":"Soltani","year":"2021","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0140","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1038\/s41375-021-01289-z","article-title":"Thyroid MALT lymphoma: self-harm to gain potential T-cell help","volume":"35","author":"Wu","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0145","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/ced.13795","article-title":"Effect of methotrexate monotherapy on T-cell subsets in the peripheral circulation in psoriasis","volume":"44","author":"Priyadarssini","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0150","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3899\/jrheum.130270","article-title":"A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders","volume":"41","author":"Yamakawa","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0155","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1001\/jama.2020.22196","article-title":"Autoimmune thyroid disease in women","volume":"325","author":"Mammen","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0160","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12876-019-0982-4","article-title":"Methotrexate-associated lymphoproliferative disorder in the stomach and duodenum: a case report","volume":"19","author":"Toyonaga","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.anndiagpath.2024.152354_bb0165","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13044-018-0051-z","article-title":"Characteristics and natural course of hypoechoic thyroid lesions diagnosed as possible thyroid lymphomas by fine needle aspiration cytology","volume":"11","author":"Nakao","year":"2018","journal-title":"Thyroid Res"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913424000911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913424000911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T06:29:04Z","timestamp":1731652144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913424000911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":33,"alternative-id":["S1092913424000911"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2024.152354","relation":{},"ISSN":["1092-9134"],"issn-type":[{"type":"print","value":"1092-9134"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathological characteristics of methotrexate-related lymphoproliferative disorder of the thyroid: A study of 11 patients","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2024.152354","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152354"}}